News Contact Us Careers Get E-Mail alerts Search

ADMA Biologics, Inc.

  • Home
  • About Us
    • About ADMA Biologics
    • What We Do
    • Who We Are
      • Senior Leadership Team
      • Board of Directors
      • Scientific Advisory Board
      • Compliance
  • Our Products
    • Products Overview
    • About Primary Immunodeficiency Disease (PI)
    • ASCENIV™
    • BIVIGAM®
    • Nabi-HB®
  • Manufacturing
    • Our Patented Process
    • Contract Manufacturing and Aseptic Fill-Finish
  • Plasma & IVIG
    • What Is Plasma?
    • Immune Globulin's Critical Role
    • Immune Globulin Production
  • Medical Affairs
    • Medical Affairs Overview
    • Publications
  • ADMA BioCenters
  • Investors
    • Overview
    • Press Releases
      • Email Alerts
    • Company Info
      • Profile
      • Presentation
      • Management Team
      • Contacts
      • FAQs
    • Analyst Coverage
    • Events & Webcasts
    • Financial Info
      • Financial Results
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Annual Reports
    • Stock Info
      • Stock Data & Quote
      • Charts
      • Historical Data
    • SEC Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Documents
  • News
  • Contact Us
  • Careers
  • Get E-Mail alerts
  • Search

You are now leaving www.admabiologics.com

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

Yes No

News

Investors

Investors

  • Overview
  • Press Releases
    • Email Alerts
  • Company Info
    • Profile
    • Presentation
    • Management Team
    • Contacts
    • FAQs
  • Analyst Coverage
  • Events & Webcasts
  • Financial Info
    • Financial Results
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Annual Reports
  • Stock Info
    • Stock Data & Quote
    • Charts
    • Historical Data
  • SEC Filings
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Documents
  • Press Releases

  • Email Alerts

Click below for current and archived news related to the company.

ADMA Biologics Highlights Launch of COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay to Detect SARS-CoV-2 Neutralizing Antibodies in Plasma
Sep 03, 2020 7:00am EDT
ADMA Biologics to Participate in Upcoming Investor Conferences
Sep 02, 2020 7:00am EDT
ADMA Biologics Reports Business Highlights and Second Quarter 2020 Financial Results
Aug 05, 2020 4:05pm EDT
ADMA Biologics to Report Business Highlights and Second Quarter 2020 Financial Results on August 5, 2020
Jul 29, 2020 7:00am EDT
ADMA Biologics Opens Its Newest ADMA BioCenters Plasma Collection Facility
Jul 06, 2020 7:00am EDT
ADMA Biologics Announces Martha J. Demski Elected to Board of Directors
Jun 23, 2020 7:00am EDT
ADMA Biologics to Participate in Jefferies Virtual Healthcare Conference
May 27, 2020 7:00am EDT
ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients
May 21, 2020 7:00am EDT
CoVIg-19 Plasma Alliance Builds Strong Momentum Through Expanded Membership and Clinical Trial Collaboration
May 08, 2020 7:00am EDT
ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent Accomplishments
May 07, 2020 7:35am EDT
  • Prev
  • 1...
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • ...24
  • Next
ADMA Biologics, Inc.
Twitter logo
LinkedIn logo
About Us Our Products Manufacturing Plasma & IVIG Medical Affairs Investors HCP Disclosure Reporting Privacy Policy Disclaimer Sitemap Contact Us Connect with Us Email Alerts RSS
Best places to work
Bio NJ

2020 Innovator Award

50 fastest companies
2022 Fast 500 Deloitte
Bio Florida

Named 2019 Company of the Year

© Copyright 2023 ADMA Biologics, Inc.
Ramsey, NJ Offices 201-478-5552
Boca Raton, FL Offices 561-989-5800
info@admabio.com